Headquartered in Lachen near Zurich, Switzerland, the Octapharma Group is a leading company in the worldwide market for therapeutic human proteins. Working at Octapharma means to have an opportunity to contribute to our common goal – developing lifesaving therapies to improve patients’ lives.
We are seeking An exciting HR Business Partner (HRBP) position has arisen in our fast-growing company’s headquarters in Lachen, Switzerland. An ideal start date would be 01.09.2019. The position is supported by a small HR team handling recruitment and operative HR tasks. The HR Business Partner is passionate about being a trusted advisor to a diverse range of 106 employees in Lachen (CH). He/she will support or lead HR change projects. This person will also provide leadership in the area of people management to local teams.
Your main responsibilities and opportunities
Your profile
Our offer
How to apply Please e-mail your application in English describing your interest, expected salary and enclosing your CV, references and/or recommendation letters to:
Deadline for applications: 09.08.2019 |
About Octapharma The vision of Octapharma is “Our passion drives us to provide new health solutions advancing human life”. Headquartered in Lachen, Switzerland, Octapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines. As a family-owned company, Octapharma believes in investing to make a difference in people’s lives and has been doing so since 1983; because it’s in our blood.Our company values are Ownership, Integrity, Leadership, Sustainability and Entrepreneurship. In 2018, the Group achieved €1.8 billion in revenue, an operating income of €346 million and invested €240 million to ensure future prosperity. Octapharma employs more than 8 300 people worldwide to support the treatment of patients in 115 countries with products across three therapeutic areas:
Octapharma owns six state-of-the-art production facilities in Austria, France, Germany, Mexico and Sweden. For more information visit www.octapharma.com |